Parkinson's disease. Refining and advancing treatment.
D000978:Antiparkinson Agents / Q000627:therapeutic use; D035843:Biomedical Research; D004298:Dopamine / Q000378:metabolism; D015259:Dopamine Agents / Q000627:therapeutic use; D006801:Humans; D009474:Neurons / Q000378:metabolism; D010300:Parkinson Disease / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D004298:Dopamine